Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 18 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 12 |
NetGPI | no | yes: 0, no: 12 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 1 |
GO:0003677 | DNA binding | 4 | 1 |
GO:0005488 | binding | 1 | 1 |
GO:0097159 | organic cyclic compound binding | 2 | 1 |
GO:1901363 | heterocyclic compound binding | 2 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 150 | 152 | PF00675 | 0.647 |
CLV_NRD_NRD_1 | 179 | 181 | PF00675 | 0.493 |
CLV_NRD_NRD_1 | 20 | 22 | PF00675 | 0.441 |
CLV_NRD_NRD_1 | 243 | 245 | PF00675 | 0.451 |
CLV_NRD_NRD_1 | 5 | 7 | PF00675 | 0.351 |
CLV_PCSK_KEX2_1 | 150 | 152 | PF00082 | 0.647 |
CLV_PCSK_KEX2_1 | 178 | 180 | PF00082 | 0.509 |
CLV_PCSK_KEX2_1 | 20 | 22 | PF00082 | 0.441 |
CLV_PCSK_KEX2_1 | 5 | 7 | PF00082 | 0.351 |
CLV_PCSK_KEX2_1 | 71 | 73 | PF00082 | 0.392 |
CLV_PCSK_PC1ET2_1 | 71 | 73 | PF00082 | 0.392 |
CLV_PCSK_SKI1_1 | 115 | 119 | PF00082 | 0.379 |
CLV_PCSK_SKI1_1 | 12 | 16 | PF00082 | 0.401 |
CLV_PCSK_SKI1_1 | 89 | 93 | PF00082 | 0.458 |
DEG_Nend_UBRbox_2 | 1 | 3 | PF02207 | 0.382 |
DEG_SCF_FBW7_2 | 233 | 239 | PF00400 | 0.423 |
DOC_CKS1_1 | 233 | 238 | PF01111 | 0.429 |
DOC_CKS1_1 | 63 | 68 | PF01111 | 0.337 |
DOC_CYCLIN_RxL_1 | 221 | 229 | PF00134 | 0.557 |
DOC_CYCLIN_yCln2_LP_2 | 230 | 236 | PF00134 | 0.377 |
DOC_MAPK_gen_1 | 119 | 128 | PF00069 | 0.272 |
DOC_MAPK_JIP1_4 | 122 | 128 | PF00069 | 0.450 |
DOC_MAPK_MEF2A_6 | 119 | 128 | PF00069 | 0.392 |
DOC_PP2B_LxvP_1 | 230 | 233 | PF13499 | 0.365 |
DOC_USP7_UBL2_3 | 115 | 119 | PF12436 | 0.336 |
DOC_WW_Pin1_4 | 232 | 237 | PF00397 | 0.424 |
DOC_WW_Pin1_4 | 62 | 67 | PF00397 | 0.331 |
DOC_WW_Pin1_4 | 80 | 85 | PF00397 | 0.401 |
LIG_14-3-3_CanoR_1 | 195 | 201 | PF00244 | 0.485 |
LIG_14-3-3_CanoR_1 | 48 | 52 | PF00244 | 0.499 |
LIG_Actin_WH2_2 | 56 | 73 | PF00022 | 0.376 |
LIG_FHA_1 | 221 | 227 | PF00498 | 0.515 |
LIG_FHA_2 | 134 | 140 | PF00498 | 0.425 |
LIG_FHA_2 | 233 | 239 | PF00498 | 0.391 |
LIG_LIR_Apic_2 | 133 | 138 | PF02991 | 0.460 |
LIG_LIR_Gen_1 | 225 | 236 | PF02991 | 0.535 |
LIG_LIR_Gen_1 | 25 | 36 | PF02991 | 0.346 |
LIG_LIR_Nem_3 | 133 | 137 | PF02991 | 0.397 |
LIG_LIR_Nem_3 | 2 | 7 | PF02991 | 0.349 |
LIG_LIR_Nem_3 | 225 | 231 | PF02991 | 0.546 |
LIG_LIR_Nem_3 | 25 | 31 | PF02991 | 0.351 |
LIG_PTB_Apo_2 | 128 | 135 | PF02174 | 0.387 |
LIG_PTB_Apo_2 | 34 | 41 | PF02174 | 0.342 |
LIG_PTB_Phospho_1 | 34 | 40 | PF10480 | 0.341 |
LIG_SH2_CRK | 4 | 8 | PF00017 | 0.330 |
LIG_SH2_NCK_1 | 135 | 139 | PF00017 | 0.448 |
LIG_SH2_SRC | 95 | 98 | PF00017 | 0.385 |
LIG_SH2_STAP1 | 40 | 44 | PF00017 | 0.345 |
LIG_SH2_STAT3 | 40 | 43 | PF00017 | 0.344 |
LIG_SH2_STAT5 | 135 | 138 | PF00017 | 0.411 |
LIG_SH2_STAT5 | 205 | 208 | PF00017 | 0.418 |
LIG_SH2_STAT5 | 234 | 237 | PF00017 | 0.404 |
LIG_SH2_STAT5 | 34 | 37 | PF00017 | 0.360 |
LIG_SH3_3 | 230 | 236 | PF00018 | 0.451 |
MOD_CK1_1 | 259 | 265 | PF00069 | 0.504 |
MOD_CK2_1 | 133 | 139 | PF00069 | 0.421 |
MOD_NEK2_2 | 196 | 201 | PF00069 | 0.410 |
MOD_PKA_2 | 47 | 53 | PF00069 | 0.487 |
MOD_Plk_2-3 | 133 | 139 | PF00069 | 0.404 |
MOD_Plk_2-3 | 152 | 158 | PF00069 | 0.553 |
MOD_Plk_4 | 256 | 262 | PF00069 | 0.509 |
MOD_Plk_4 | 47 | 53 | PF00069 | 0.487 |
MOD_ProDKin_1 | 232 | 238 | PF00069 | 0.418 |
MOD_ProDKin_1 | 62 | 68 | PF00069 | 0.333 |
MOD_ProDKin_1 | 80 | 86 | PF00069 | 0.399 |
TRG_DiLeu_BaLyEn_6 | 238 | 243 | PF01217 | 0.359 |
TRG_ENDOCYTIC_2 | 114 | 117 | PF00928 | 0.349 |
TRG_ENDOCYTIC_2 | 234 | 237 | PF00928 | 0.388 |
TRG_ENDOCYTIC_2 | 4 | 7 | PF00928 | 0.338 |
TRG_ER_diArg_1 | 149 | 151 | PF00400 | 0.607 |
TRG_ER_diArg_1 | 177 | 180 | PF00400 | 0.445 |
TRG_ER_diArg_1 | 20 | 22 | PF00400 | 0.443 |
TRG_ER_diArg_1 | 213 | 216 | PF00400 | 0.464 |
TRG_ER_diArg_1 | 4 | 6 | PF00400 | 0.347 |
TRG_ER_diArg_1 | 72 | 75 | PF00400 | 0.395 |
TRG_Pf-PMV_PEXEL_1 | 103 | 107 | PF00026 | 0.395 |
TRG_Pf-PMV_PEXEL_1 | 20 | 25 | PF00026 | 0.432 |
TRG_Pf-PMV_PEXEL_1 | 224 | 229 | PF00026 | 0.553 |
TRG_Pf-PMV_PEXEL_1 | 271 | 275 | PF00026 | 0.425 |
TRG_Pf-PMV_PEXEL_1 | 285 | 289 | PF00026 | 0.484 |
TRG_Pf-PMV_PEXEL_1 | 5 | 9 | PF00026 | 0.331 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PCB7 | Leptomonas seymouri | 84% | 100% |
A0A0S4IJG6 | Bodo saltans | 60% | 91% |
A0A1X0NT90 | Trypanosomatidae | 71% | 97% |
A0A381MHF5 | Leishmania infantum | 93% | 98% |
A0A3Q8IAP3 | Leishmania donovani | 93% | 98% |
A0A3S7WX26 | Leishmania donovani | 93% | 98% |
A0A422NDI7 | Trypanosoma rangeli | 75% | 100% |
C9ZSF8 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 72% | 100% |
E9AVQ5 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 93% | 80% |
Q4QBR4 | Leishmania major | 93% | 100% |
V5DMI7 | Trypanosoma cruzi | 73% | 88% |